ArticleHelicobacter
Journey Towards Piloting Helicobacter pylori Screen-and-Treat to Address Health Inequities in Aotearoa New Zealand.
Article in Helicobacter. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From screening to surveillance: integrated prevention ofThe Lancet regional health. Western Pacific · 2026Review
- Plasma proteome-wide Mendelian randomization reveals multi-ancestry drug targets for gastric cancer.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundMāori and Pacific peoples in Aotearoa New Zealand (Aotearoa) face the greatest barriers to healthcare access, poorest health outcomes, and disproportionate levels of deprivation.
methodsThis paper outlines the (1) epidemiology of H. pylori and its sequelae, (2) inequities in the current H. pylori approach, (3) research into screen-and-treat, and (4) our recommendations going forward.
resultsThere are stark ethnic differences in prevalence of H. pylori infection and its sequelae in Aotearoa-with higher H. pylori infection prevalence and gastric cancer incidence and higher numbers of hospitalisations for peptic ulcer in Māori, Pacific, and Asian ethnicities than in European. The opportunistic approach taken to H. pylori testing has created inequities. Māori and Pacific are less likely to be tested for H. pylori than European, despite the higher prevalence of infection in these populations. In Aotearoa, a targeted screen-and-treat approach has been shown to be more cost-effective than a population-wide strategy.
conclusionThere is an urgent need to introduce a screen-and-treat pilot in Aotearoa, which should be led by Māori. Piloting of screen-and-treat is useful for evaluating invitation, testing and treatment strategies. Further cost-effectiveness modeling could support the evaluation of more specific targeting, test choice, and treatment choice where input data allow.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.